Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

UTI - MNC Fund · Regular ✕HDFC Pharma and Healthcare Fund · Regular ✕

Growth of ₹10,000

Basics

UTI - MNC FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseUTIHDFC
NAV₹204.7912₹22.6640
NAV date19 Nov 202619 Nov 2026
History—3.1 years
Expense ratio2.2%2.1%
StarsNot rated★★★★★
Growth Score—93.90

Returns

UTI - MNC FundHDFC Pharma and Healthcare Fund
1 month—+12.11%
3 months—+6.07%
6 months—+16.75%
YTD—+31.54%
1 year—+30.13%
3 years (CAGR)—+29.02%
5 years (CAGR)——
10 years (CAGR)——
Since launch—+30.03%

Risk

UTI - MNC FundHDFC Pharma and Healthcare Fund
Volatility—15.7%
Downside volatility—8.6%
Sharpe—1.44
Sortino—2.62
Calmar—1.93
Return / risk—1.85
Deepest fall—−15.07%
Days to recover—133
Below its high—−0.21%

Against benchmark

UTI - MNC FundHDFC Pharma and Healthcare Fund
Alpha—+6.18%
Beta—0.97
R²—85.3%
Up capture—106.1%
Down capture—74.4%
Tracking error—6.0%
Information ratio—0.95
Treynor—0.22

Consistency

UTI - MNC FundHDFC Pharma and Healthcare Fund
Best 1-year—+64.96%
Middle 1-year—+21.84%
Worst 1-year—+0.52%
1-year periods with a loss—0.0%
Middle 3-year—+28.64%
Positive months—69.4%
Best day—+3.19%
Worst day—−3.62%
Worst 5% day—−1.50%
Positive days—58.1%
NAVs a year—247

SIP of ₹10,000 a month

UTI - MNC FundHDFC Pharma and Healthcare Fund
5-year XIRR——
5-year value——
3-year XIRR—+25.83%
1-year XIRR—+38.53%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth